Category

Publications
Research Article Abstract Introduction: Preventive therapy is essential for reducing tuberculosis (TB) burden among people living with HIV (PLWH) in high-burden settings. Short-course preventive therapy regimens, such as three-month weekly rifapentine and isoniazid (3HP) and one-month daily rifapentine and isoniazid (1HP), may help facilitate uptake of preventive therapy for latently infected patients, but the comparative...
Read More
The aim of the target product profiles (TPPs) for TPT is to identify the product attributes to be considered in developing the best, most suitable TB prevention treatments. These TPPs are expected to assist developers in aligning the characteristics of new treatment regimens and developers’ performance and operational targets with national requirements. This document describes...
Read More
Latent Tuberculosis Infection: A Guide for Primary Health Care Providers pdf icon[PDF – 4 MB] is intended for primary care providers who care for individuals and populations who may be at risk for infection with M. tuberculosis. The guide includes latent TB infection diagnosis and treatment information, sample documentation forms, and additional resources. This document is not meant...
Read More
WHO operational handbook on Tuberculosis Module 1: Prevention Tuberculosis Preventive Treatment The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
Read More
Publication: WHO consolidated guidelines on Tuberculosis Module 1: Prevention Tuberculosis preventive treatment The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be...
Read More
1 2 3